Atea Pharmaceuticals, Inc.
2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT

Last updated:

Abstract:

The use of described compounds or pharmaceutically acceptable salts or compositions thereof for the treatment of a host infected with an RNA virus other than HCV, or other disorder more fully described herein.

Status:
Application
Type:

Utility

Filling date:

17 Mar 2020

Issue date:

16 Jul 2020